Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Unraveling TP53 -Mutated Acute Myeloid Leukemia : Clinical Insights and Genetic Profiles

Songyi Park, Sang-A Kim, Ji Yun Lee, Ja Min Byun, Jeong-Ok Lee, Youngil Koh, Junshik Hong, Junglim Lee, Soo-Mee Bang, Inho Kim, Sung-Soo Yoon, Dongyeop Shin

Blood (2024) 144 (Supplement 1): 5944.

https://doi.org/10.1182/blood-2024-202293

Published: 2024

Journal Articles

Spectrum of TP53 Mutation in Hematologic Malignancies

Seo Yoon Jang, Joowon Jang, Jee-Soo Lee, Songyi Park, Ja Min Byun, Youngil Koh, Junshik Hong, Inho Kim, Sung-Soo Yoon, Dong-Yeop Shin

Blood (2024) 144 (Supplement 1): 5731.

https://doi.org/10.1182/blood-2024-210051

Published: 2024

Journal Articles

ATR Inhibitor Elimusertib Suppresses Drug Persister Clones in TP53 -Mutated Acute Myeloid Leukemia Via CGAS-Sting-Mediated Cell Death

Dongchan Kim, Daehyeon Gwak, Ja Min Byun, Youngil Koh, Junshik Hong, Jung Lim Lee, Sung-Soo Yoon, Dong-Yeop Shin

Blood (2024) 144 (Supplement 1): 1375.

https://doi.org/10.1182/blood-2024-202733

Published: 2024

Journal Articles

PHI-101, a Novel FLT3 TKI, Shows Clinical Efficacy in Relapsed/Refractory FLT3-Mutated AML

Blood (2024) 144 (Supplement 1): 1495.

https://doi.org/10.1182/blood-2024-207033

Published: 2024

Journal Articles

Differences in Clinical Outcomes between Hydroxyurea-Resistant and -Intolerant Polycythemia Vera Patients

Sung-Yong Kim, Sung-Eun Lee, Junshik Hong, Soo-Mee Bang, Jinny Park, Chul Won Choi, Sung Hwa Bae, Min Kyoung Kim, Seug Yun Yoon

Blood (2023) 142 (Supplement 1): 1818.

https://doi.org/10.1182/blood-2023-177822

Published: 2023

Journal Articles

A Global, Phase 3, Randomized, Double-Blind Study to Evaluate Safety and Efficacy of Selinexor, an XPO-1 Inhibitor, in Combination with Ruxolitinib in JAK Inhibitor-Naïve Myelofibrosis (XPORT-MF-034)

Keri Maher, Raajit K. Rampal, Prithviraj Bose, Nikolai A. Podoltsev, Claire N Harrison, Junshik Hong, Xulong Wang, Kamal Chamoun, John Mascarenhas

Blood (2023) 142 (Supplement 1): 3209.

https://doi.org/10.1182/blood-2023-180695

Published: 2023

Journal Articles

T-Cell Depletion with Both Reduced Dose Anti-Thymocyte Globulin and Reduced Dose Post-Transplant Cyclophosphamide in Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Leukemia and Myelodysplatic Syndrome

Junshik Hong, Dong Hyun Kim, Ja Min Byun, Dongyeop Shin, Youngil Koh, Inho Kim, Sung-Soo Yoon, Hyun Jung Lee, Jung Lim Lee

Blood (2023) 142 (Supplement 1): 7000.

https://doi.org/10.1182/blood-2023-185845

Published: 2023

Journal Articles

A Prospective Randomized Study for Optimal Red Blood Cell Use Patients with Acute Myeloid Leukemia Receiving Dose Intensive Chemotherapy

Ja Min Byun, Junshik Hong, Dong-Yeop Shin, Youngil Koh, Sung-Soo Yoon, Inho Kim, Hyungsuk Kim

Blood (2022) 140 (Supplement 1): 81–82.

https://doi.org/10.1182/blood-2022-157619

Published: 2022

Journal Articles

Programmed Death-1 Homolog (PD-1H/VISTA) Blockade Confers a Synergistic Anti-Leukemia Effect with PD-1 Blockade

Tae Kon Kim, Xue Han, Qianni Hu, Carly Hedgepath, Junshik Hong, Jihyun Park, Emily F Mason, Lieping Chen

Blood (2022) 140 (Supplement 1): 87–88.

https://doi.org/10.1182/blood-2022-158314

Published: 2022

Journal Articles

Serum Erythropoietin As an Early Marker for Hidden Hematologic Malignancy in Anemia of Unknown Etiology

Seong Juyong, Dong-Yeop Shin, Ja Min Byun, Youngil Koh, Junshik Hong, Inho Kim, Sung-Soo Yoon

Blood (2022) 140 (Supplement 1): 8164–8165.

https://doi.org/10.1182/blood-2022-155698

Published: 2022

Journal Articles

HDAC Inhibition Effectively Induce Apoptosis in Diffuse Large B Cell Lymphoma with High Bfl-1

Eunchae Park, Chansub Lee, Jihyun Park, Jun Liu, Junshik Hong, Dong-Yeop Shin, Ja Min Byun, Youngil Koh, Sung-Soo Yoon

Blood (2021) 138 (Supplement 1): 4320.

https://doi.org/10.1182/blood-2021-148277

Published: 2021

Journal Articles

A Pilot Study of MG4101, Allogeneic Natural Killer Cell, in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Sang A Kim, Youngil Koh, Miyoung Jung, Yu Kyeong Hwang, Ja Min Byun, Junshik Hong, Dong-Yeop Shin, Inho Kim, Sung-Soo Yoon

Blood (2021) 138 (Supplement 1): 3835.

https://doi.org/10.1182/blood-2021-152137

Published: 2021

Journal Articles

A Novel Lair-1 Antibody Selectively Targets Acute Myeloid Leukemia (AML) Stem Cells

Linjie Tian, Ana Paucarmayta, Rustin Lovewell, Karla Maloveste, Junshik Hong, Carly Hedgepath, Kwang Woon Kim, Ron Copeland, Thomas O'Neill, Shashank Patel, Linda N. Liu, Han Myint, Solomon Langermann, Dallas B Flies, Tae Kon Kim

Blood (2021) 138 (Supplement 1): 3413.

https://doi.org/10.1182/blood-2021-147656

Published: 2021

Journal Articles

Older Age Instead of Body Mass Index Predicts Cancer-Associated Thrombosis: Validation of Khorana Score in Cancer Patients Undergoing Chemotherapy with East Asian Ethnicity

Junshik Hong, Hyerim Ha, YeHee Ko, Kwangsoo Kim

Blood (2021) 138 (Supplement 1): 2124.

https://doi.org/10.1182/blood-2021-149714

Published: 2021

Journal Articles

Leukemic Stem Cell Phenotype Is Associated with Mutational Profile in Acute Myeloid Leukemia

Ja Min Byun, MD, Dong-Yeop Shin, MD PhD, Youngil Koh, Sung-Soo Yoon, MD PhD, Junshik Hong, MD, Inho Kim, MD PhD

Blood (2019) 134 (Supplement_1): 3852.

https://doi.org/10.1182/blood-2019-126373

Published: 2019

Journal Articles

A Nationwide Epidemiologic Study for Disease Transformation and Secondary Cancers in Korean Patients with Myeloproliferative Neoplasms

Junshik Hong, MD, Ju Hyun Lee, Ja Min Byun, MD, Ji Yun Lee, MD, Hyun Jung Lee, MD, Sang Mee Hwang, MD PhD, Byung-Su Kim, MD PhD, Hyo Jung Kim, MD PhD, Jung Lim Lee, MD, Dong-Yeop Shin, MD PhD, Youngil Koh, MD PhD, Sung-Soo Yoon, MD PhD, Soo-Mee Bang, MD PhD

Blood (2018) 132 (Supplement 1): 4314.

https://doi.org/10.1182/blood-2018-99-116298

Published: 2018

Journal Articles

Genomic and Immune Profiles of Multiple Myeloma Revealed By Whole Genome and Transcriptome Sequencing

Christopher J. Yoon, MPhil, Hyojin Song, Seulki Song, Hyejoo Park, Dong-Yeop Shin, MD PhD, Junshik Hong, MD, Inho Kim, MD PhD, Hyun Jung Lee, MD, Byung-Su Kim, MD PhD, Jung Lim Lee, MD, Sung-Soo Yoon, MD PhD, Young Seok Ju, Youngil Koh, MD PhD

Blood (2018) 132 (Supplement 1): 4493.

https://doi.org/10.1182/blood-2018-99-117546

Published: 2018

Journal Articles

Therapy-Related Myeloid Neoplasms Are Not Always Dismal If They Have Better Cytogenetic Profile and Longer Latency Period from Preceding Anti-Cancer Treatment

Junshik Hong, MD, Ji Yun Lee, MD, Ja Min Byun, MD, Dong-Yeop Shin, MDPhD, Youngil Koh, MD, Inho Kim, MD PhD, Sung-Soo Yoon, MD PhD

Blood (2017) 130 (Supplement 1): 1307.

https://doi.org/10.1182/blood.V130.Suppl_1.1307.1307

Published: 2017

Journal Articles

Clinical Dissection of Infectious Event Following ATG Treatment for Aplastic Anemia and Hypoplastic Myelodysplastic Syndrome Reveals Urgent Need for Anti-Aspergillus Prophylaxis

Hee-Ryeong Jang, MD, Sung-Soo Yoon, MD PhD, Inho Kim, MD PhD, Soo-Mee Bang, MD PhD, Junshik Hong, MD, Dong-Yeop Shin, MDPhD, Ji Yun Lee, MD, Jeong-Ok Lee, MD, Byung-Su Kim, MD PhD, Hyo Jung Kim, MD PhD, Wan Beom Park, MD PhD, Nam Joong Kim, MD PhD, Youngil Koh, MD

Blood (2017) 130 (Supplement 1): 2463.

https://doi.org/10.1182/blood.V130.Suppl_1.2463.2463

Published: 2017

Journal Articles

The Role of FDG PET for Evaluation of Bone Marrow Status and Prognosis in T Cell Lymphomas

Go-Un Woo, Jung Min Lee, Youngil Koh, MD, Jin Chul Paeng, Youk Jeonghwan, Sung-Soo Yoon, MD PhD, Inho Kim, MD PhD, Dong-Yeop Shin, MDPhD, Junshik Hong, MD, Hyo Jung Kim, MD PhD, Hyun Jung Lee, MD

Blood (2017) 130 (Supplement 1): 1517.

https://doi.org/10.1182/blood.V130.Suppl_1.1517.1517

Published: 2017

NARROW

Unraveling TP53 -Mutated Acute Myeloid Leukemia : Clinical Insights and Genetic Profiles

Spectrum of TP53 Mutation in Hematologic Malignancies

ATR Inhibitor Elimusertib Suppresses Drug Persister Clones in TP53 -Mutated Acute Myeloid Leukemia Via CGAS-Sting-Mediated Cell Death

PHI-101, a Novel FLT3 TKI, Shows Clinical Efficacy in Relapsed/Refractory FLT3-Mutated AML

Differences in Clinical Outcomes between Hydroxyurea-Resistant and -Intolerant Polycythemia Vera Patients

A Global, Phase 3, Randomized, Double-Blind Study to Evaluate Safety and Efficacy of Selinexor, an XPO-1 Inhibitor, in Combination with Ruxolitinib in JAK Inhibitor-Naïve Myelofibrosis (XPORT-MF-034)

T-Cell Depletion with Both Reduced Dose Anti-Thymocyte Globulin and Reduced Dose Post-Transplant Cyclophosphamide in Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Leukemia and Myelodysplatic Syndrome

A Prospective Randomized Study for Optimal Red Blood Cell Use Patients with Acute Myeloid Leukemia Receiving Dose Intensive Chemotherapy

Programmed Death-1 Homolog (PD-1H/VISTA) Blockade Confers a Synergistic Anti-Leukemia Effect with PD-1 Blockade

Serum Erythropoietin As an Early Marker for Hidden Hematologic Malignancy in Anemia of Unknown Etiology

HDAC Inhibition Effectively Induce Apoptosis in Diffuse Large B Cell Lymphoma with High Bfl-1

A Pilot Study of MG4101, Allogeneic Natural Killer Cell, in Patients with Relapsed or Refractory Acute Myeloid Leukemia

A Novel Lair-1 Antibody Selectively Targets Acute Myeloid Leukemia (AML) Stem Cells

Older Age Instead of Body Mass Index Predicts Cancer-Associated Thrombosis: Validation of Khorana Score in Cancer Patients Undergoing Chemotherapy with East Asian Ethnicity

Leukemic Stem Cell Phenotype Is Associated with Mutational Profile in Acute Myeloid Leukemia

A Nationwide Epidemiologic Study for Disease Transformation and Secondary Cancers in Korean Patients with Myeloproliferative Neoplasms

Genomic and Immune Profiles of Multiple Myeloma Revealed By Whole Genome and Transcriptome Sequencing

Therapy-Related Myeloid Neoplasms Are Not Always Dismal If They Have Better Cytogenetic Profile and Longer Latency Period from Preceding Anti-Cancer Treatment

Clinical Dissection of Infectious Event Following ATG Treatment for Aplastic Anemia and Hypoplastic Myelodysplastic Syndrome Reveals Urgent Need for Anti-Aspergillus Prophylaxis

The Role of FDG PET for Evaluation of Bone Marrow Status and Prognosis in T Cell Lymphomas

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only